BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34591226)

  • 21. Surgical outcomes of hepatocellular carcinoma with extrahepatic bile duct tumor thrombus: a multicenter study.
    Huang LM; Zeng ZX; Wu JY; Li YN; Wang JX; Fu YK; Wu JY; Wei SM; Lv JH; Chen WZ; Huang RF; Cheng SQ; Yan ML
    Front Oncol; 2023; 13():1291479. PubMed ID: 38111530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis.
    Lin CW; Wu TC; Lin HY; Hung CM; Hsieh PM; Yeh JH; Hsiao P; Huang YL; Li YC; Wang YC; Shu CW; Chen YS
    BMC Gastroenterol; 2021 Jan; 21(1):20. PubMed ID: 33413162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival analysis of liver transplantation for hepatocellular carcinoma with bile duct tumor thrombus.
    Ha TY; Hwang S; Moon DB; Ahn CS; Kim KH; Song GW; Jung DH; Park GC; Park HW; Park YH; Kang SH; Jung BH; Lee SG
    Transplant Proc; 2014 Apr; 46(3):774-7. PubMed ID: 24767346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis for patients with hepatocellular carcinoma (HCC) with bile duct tumor thrombus (BDTT) after surgical treatment.
    Lin Z; Han M; Zhou Z
    Biosci Trends; 2019 Mar; 13(1):77-85. PubMed ID: 30814401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Comparison Between Liver Resection and Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Bile Duct Tumor Thrombus: A Propensity-Score Matching Analysis.
    Liu ZH; Sun JX; Feng JK; Yang SY; Chen ZH; Liu C; Chai ZT; Mao FF; Guo WX; Shi J; Cheng SQ
    Front Oncol; 2022; 12():835559. PubMed ID: 35372001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korean multicenter study.
    Moon DB; Hwang S; Wang HJ; Yun SS; Kim KS; Lee YJ; Kim KH; Park YK; Xu W; Kim BW; Lee DS; Lee DH; Kim HJ; Lim JH; Choi JS; Park YH; Lee SG
    World J Surg; 2013 Feb; 37(2):443-51. PubMed ID: 23188531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus.
    Navadgi S; Chang CC; Bartlett A; McCall J; Pandanaboyana S
    HPB (Oxford); 2016 Apr; 18(4):312-6. PubMed ID: 27037199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study.
    Xia F; Zhang Q; Ndhlovu E; Zheng J; Yuan M; Gao H; Xia G
    Surg Endosc; 2024 Feb; 38(2):799-812. PubMed ID: 38062182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caution for diagnosis and surgical treatment of recurrent cholangitis: lessons from 5 cases of bile duct tumor thrombus without a detectable intrahepatic tumor.
    Wu Z; Guo K; Sun H; Yu L; Lv Y; Wang B
    Medicine (Baltimore); 2014 Sep; 93(11):e80. PubMed ID: 25192487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pure Laparoscopic Right Hepatectomy for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus (with Video).
    Funamizu N; Mishima K; Ozaki T; Nakanishi K; Igarashi K; Omura K; Takada Y; Wakabayashi G
    Ann Surg Oncol; 2021 Mar; 28(3):1511-1512. PubMed ID: 32803552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0-A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis.
    Yang SY; Yan ML; Duan YF; Feng JK; Ye JZ; Xiang YJ; Liu ZH; Guo L; Xue J; Cheng SQ; Guo WX
    Hepatol Int; 2022 Aug; 16(4):892-905. PubMed ID: 35704267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.
    Cheng YQ; Wang K; Zhang XP; Wei XB; Jiang YB; Hu YR; Mao FF; Guo WX; Shi J; Cheng SQ
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1214-1221. PubMed ID: 30402968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
    Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
    J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of bile duct tumor thrombus on the long-term prognosis of hepatocellular carcinoma patients after liver resection: a systematic review and meta-analysis.
    Feng JK; Wu YX; Chen ZH; Sun JX; Wang K; Chai ZT; Shi J; Guo WX; Cheng SQ
    Ann Transl Med; 2020 Dec; 8(24):1683. PubMed ID: 33490195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of primary tumor location with long-term oncological prognosis following hepatectomy for hepatocellular carcinoma:A multicenter propensity score matching analysis.
    Tang SC; Lin KY; Huang TF; Zhang KL; Kong J; He XL; Luo C; Chen QJ; Guo PF; Zhou WP; Zeng YY
    Eur J Surg Oncol; 2023 Jul; 49(7):1234-1241. PubMed ID: 36774217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
    Yamashita YI; Hayashi H; Imai K; Okabe H; Nakagawa S; Kitamura F; Uemura N; Nakao Y; Yusa T; Itoyama R; Yamao T; Umesaki N; Miyata T; Chikamoto A; Shimokawa M; Baba H
    World J Surg; 2019 Nov; 43(11):2894-2901. PubMed ID: 31312946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vater Papilla-preserving Strategy for Advanced Hepatocellular Carcinoma With Excessive Bile Duct Tumor Thrombus.
    Yamamura K; Beppu T; Inoue K; Matsumura K; Oda E; Nagayama Y; Motohara T; Miyamoto H; Komohara Y; Okabe H; Miyata T; Isiko T
    Anticancer Res; 2022 Nov; 42(11):5663-5670. PubMed ID: 36288845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma.
    Wu JY; Sun JX; Wu JY; Huang XX; Bai YN; Zeng YY; Zhang ZB; Cheng SQ; Yan ML
    BMC Cancer; 2021 Mar; 21(1):272. PubMed ID: 33711965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.